AIDS Weekly articles from July 1991

AIDS Weekly archives from July 1991

Senate approves jail terms for HIV non-disclosure. (Washington, D.C.) (Healthcare professionals tested positive for HIV infection)
July 29, 1991... DATELINE: Washington, D.C. On July 18, 1991, the U.S. Senate approved and sent to the House of Representatives legislation that would impose fines of $10,000 and jail terms of up to 10 years on healthcare professionals who have tested...

Senate action called extreme. (California Dental Association) (HIV infected healthcare workers)
July 29, 1991... DATELINE: California Dental Association In the wake of U.S. Senate action aimed at forcing HIV-infected healthcare workers out of practice, the California Dental Association (CDA) expressed deep concern and reaffirmed its commitment to...

Organized nursing opposes Helms Amendment. (Michigan Nurses Association) (mandatory testing and disclosure of hiv status of patients and nurses)
July 29, 1991... DATELINE: Michigan Nurses Association The following statement was released July 19 by the Michigan Nurses Association (MNA): The Michigan Nurses Association opposes mandatory testing and mandatory disclosure of HIV status of...

Women poorly represented in AIDS clinical trials. (VII International Conference on AIDS)
July 29, 1991... DATELINE: VII International Conference on AIDS Women are underrepresented in AIDS clinical trials, Harvard researcher Deborah Cotton reported at the VII International Conference on AIDS. Not only are women underrepresented as...

Response to CDC guidelines on infection control issued. (American Dental Association) (HIV-infected dentists)
July 29, 1991... DATELINE: American Dental Association The American Dental Association (ADA) has reviewed the U.S. Centers for Disease Control (CDC) guidelines published in the July 12, 1991, Morbidity & Mortality Weekly Report. According to the ADA,...

Group adopts AIDS infection control policy. (Academy of General Dentistry)
July 29, 1991... DATELINE: Academy of General Denistry The 32,000-member Academy of General Dentistry (AGD) adopted a policy at its annual meeting in July calling for universal adherence by dentists to strict infection control and sterilization...

AIDS guidelines sound, nurses say. (American Nurses Association) (Centers for Disease Control)
July 29, 1991... DATELINE: American Nurses Association New federal guidelines on bloodborne diseases including AIDS and hepatitis B are scientifically sound and correct, the American Nurses Association (ANA) said. "The emphasis is appropriately on...

Statement issued on guidelines for preventing transmission in healthcare settings. (American Association of Blood Banks) (human immunodeficiency virus and hepatitis B virus)
July 29, 1991... DATELINE: American Association of Blood Banks The American Association of Blood Banks (AABB) has issued a statement in support of the U.S. Centers for Disease Control's new guidelines, Recommendations for Preventing Transmission of...

Barr Laboratories granted license under AZT patents. (U.S. National Institutes of Health)
July 29, 1991... DATELINE: U.S. NIH The U.S. National Institutes of Health (NIH) has granted Barr Laboratories Inc. license rights for AZT. AZT or zidovudine is widely used in the treatment of AIDS and AIDS-Related Complex in adults and children....

Company responds to NIH licensing action. (Burroughs Wellcome) (National Institutes of Health)
July 29, 1991... DATELINE: Burroughs Wellcome The following was released July 17, 1991, by Burroughs Wellcome: The announcement by Barr Laboratories that it signed a license which purports to confer on Barr the alleged interest of NIH in AZT...

Medical guidebook for people with HIV released. (Johns Hopkins Hospital)
July 29, 1991... DATELINE: Johns Hopkins Hospital "The absence of a medically reliable guidebook for people affected by AIDS, ARC, or HIV has been one of the most crippling aspects of this epidemic," says John G. Bartlett, M.D., director of the...

New drug inhibits key genetic sequence of HIV. (Isis Pharmaceuticals) (oligonucleotides)
July 29, 1991... DATELINE: Isis Pharmaceuticals Scientists at Isis Pharmaceuticals Inc. have constructed a series of oligonucleotides - rationally designed drugs which selectively bind to molecules of messenger RNA - which have been shown in vitro to...

Vaccine for monkeys 'opens the way' for human version. (Germany) (AIDS vaccine)
July 29, 1991... DATELINE: Germany Researchers at the Goettingen Primate Center Lower Saxony Germany, say that they have developed the first effective AIDS vaccine. Gerhard Hunsmann, director of AIDS research at the center, said that the vaccine had...

FDA approves procysteine for human clinical trials. (Clintec)
July 29, 1991... DATELINE: Clintec Clintec Nutrition Company, Deerfield, Illinois, announced that it has received approval from the U.S. Food and Drug Administration (FDA) to begin Phase I, controlled human clinical trials with Procysteine, a precursor...

Product patent granted for a class of liposomes. (The Liposome Co.)
July 29, 1991... DATELINE: The Liposome Company The Liposome Company, Inc., Princeton, New Jersey, announced that it has been granted a patent covering a broad category of multilamellar liposomes. U.S. Patent No. 5,030,453 also covers therapeutic...

Receptor is key to treating chronic and acute inflammation. (Repligen Corporation) (interleukin-8)
July 29, 1991... DATELINE: Repligen Corporation Repligen Corporation announced that it has obtained an exclusive license from Boston University to a novel molecule that is expected to be useful in developing therapeutic agents for a variety of...

Company awarded $3.2 million five-year AIDS pre-clinical contract. (TSI Corp.)(AIDS vaccine for humans)
July 29, 1991... DATELINE: TSI Corporation TSI Corporation, Worcester, Massachusetts, announced that it has been awarded a five-year contract for $3.2 million from the National Institute of Allergy and Infectious Diseases (NIAID) to conduct...

Company to acquire PCR technology from Cetus. (Hoffmann-La Roche) (polymerase chain reaction)
July 29, 1991... DATELINE: Hoffmann-La Roche Under a series of agreements, Hoffmann-La Roche (Roche) will acquire ownership of the revolutionary polymerase chain reaction (PCR) technology from Cetus Corporation. At the same time, the Perkin-Elmer...

Company announces intent to acquire interest in Lipidex Laboratories. (International Murex Technologies)
July 29, 1991... DATELINE: International Murex Technologies International Murex Technologies Corporation (IMTC) announced that the company has signed a letter of intent to acquire a 25 percent interest in Lipidex Laboratories Inc. of Toronto, Canada....

Licensing agreement with Zenyaku Kogyo announced. (IDEC Pharmaceuticals)
July 29, 1991... DATELINE: IDEC Pharmaceuticals IDEC Pharmaceuticals Corporation and Zenyaku Kogyo Co. Ltd. have entered into an agreement under which IDEC Pharmaceuticals will receive $9.5 million in return for certain product rights and a minority...

Research on relationships between alcohol use and sexual behaviors associated with HIV transmission. (Research Report)
July 29, 1991... AUTHORS: PA: PA-91-75. National Institute on Alcohol Abuse and Alcoholism. Research Objectives of NIAAA: Under this announcement, researchers are encouraged to study possible relationships between alcohol use and unsafe sexual...

HIV may develop resistance preferentially to azidothymidine (AZT) as compared to dideoxycytidine (ddC) and dideoxyinosine (ddI) in patients receiving antiviral therapy. (Research Report)
July 29, 1991... AUTHORS: Takuma Shirasaka, R. Yarchoan, R. Husson, T. Shimada, K.M. Wyvill, S. Broder and H. Mitsuya. U.S. National Cancer Institute, National Heart, Lung, and Blood Institute, Bethesda, Maryland. According to an abstract submitted by...

Change in AIDS risk behaviors from adolescence to adulthood. (Research Report)
July 29, 1991... AUTHORS: Arlene Rubin Stiffman, R. Cunningham, F. Earls and P. Dore. Washington University, St. Louis, Missouri; Harvard University, Boston, Massachusetts. According to an abstract submitted by the authors to the VII International...

Immunization of Simian immunodeficiency virus-infected Rhesus monkeys with soluble human CD4 elicits an antiviral response. (Periodical Report)
July 29, 1991... SOURCE: Proceedings of the National Academy of Sciences, June 1991;88(11):4616-4620. The finding that immunization of SIV-infected rhesus monkeys with human CD4 stimulates an antiviral response -and provides a therapeutic effect -...

Ranitidine improves certain cellular immune responses in asymptomatic HIV-infected individuals. (Periodical Report)
July 29, 1991... SOURCE: Journal of Acquired Immune Deficiency Syndromes, June 1991;4(6):577-584. The anti-ulcer drug ranitidine (Zantac, Glaxo Pharmaceuticals) improves but does not reverse cellular immune responses in individuals with asymptomatic...

Full length CD4 electroinserted in the erythrocyte membrane as a long-lived inhibitor of infection by human immunodeficiency virus. (Periodical Report)
July 29, 1991... SOURCE: Proceedings of the National Academy of Sciences, May 1991;88(10):4409-4413. Red blood cells containing CD4 receptor molecules may represent a new AIDS therapy, suggest researchers from Columbia and Texas A&M universities. ...

The P15 carboxyl-terminal proteolysis product of the human immunodeficiency virus type 1 reverse transcriptase P66 has DNA polymerase activity. (Periodical Report)
July 29, 1991... SOURCE: Proceedings of the National Academies of Science, June 15, 1991;88(12):5262-5266. HIV-1 apparently has not one, but two functional reverse transcriptases, Swiss researchers report. Peter Hafkemeyer and colleagues of the...

Relative prevalence and risk factors of HTLV-I and HTLV-II infection in U.S. blood donors. (Periodical Report)
July 29, 1991... SOURCE: The Lancet, June 15, 1991;337(8755):1435-1439. Human T-cell lymphotropic virus (HTLV) seroprevalence in the U.S. is 3.3 times greater than the prevalence of HIV-1, a study of U.S. blood donors shows. A surprisingly large...

Benefits and costs of HIV testing.
July 29, 1991... SOURCE: Science, June 28, 1991;252(5014):1798-1804. HIV testing of job applicants is not cost effective for most firms, a Columbia University study shows. In their analysis of the costs and benefits of HIV testing by employers,...

The initial immune response to HIV and immune system activation determine the outcome of HIV disease.
July 29, 1991... SOURCE: Journal of Acquired Immune Deficiency Syndromes, July 1991;4(7):704-712. Data from a prospective study indicate that the outcome of HIV disease depends upon two independent factors: whether a person initially has a strong,...

New guidelines issued for healthcare workers with HIV. (U.S. Centers for Disease Control)
July 22, 1991... U.S. Centers for Disease Control U.S. Department of Health and Human Services (HHS) Secretary Louis W. Sullivan, M.D., announced new guidelines which say that healthcare workers with HIV should not perform "exposure-prone" medical...

AMA reacts to CDC guidelines on HIV transmission by healthcare workers. (Chicago, American Medical Association)
July 22, 1991... Chicago The following statement was released July 15, 1991, by Nancy W. Dickey, M.D., member, American Medical Association (AMA) board of trustees: The American Medical Association is pleased that the Centers for Disease Control...

Haseltine stresses mucosal membrane as main site of HIV entry. (VII International Conference on AIDS; William A. Haseltine)
July 22, 1991... VII International Conference on AIDS "The virus needs no other port of entry than the mucous membrane," stressed William A. Haseltine during his keynote address to a plenary session of the VII International Conference on AIDS. ...

Researchers find important cause of malnutrition in AIDS patients. (University of California, Davis)
July 22, 1991... University of California, Davis Researchers at the University of California (UC) at Davis, announced they have discovered an important cause of malnutrition in AIDS patients: HIV attacks intestinal cells that absorb nutrients, and it...

A natural defense against HIV. (University of California, San Francisco)
July 22, 1991... University of California, San Francisco As pharmacologists all over the world were searching for a new molecule capable of killing HIV, Jay A. Levy of the Department of Medicine and Cancer Research Institute of the University of...

Study shows improved survival rates of AIDS cases. (San Francisco, California)
July 22, 1991... San Francisco, California The percentage of San Francisco HIV-positives who are still alive at least two years after diagnosis has virtually doubled since 1981. George Lemp of the San Francisco Department of Public Health...

Continued patient improvement reported in 12-month AIDS treatment. (Immuvax)
July 22, 1991... Immuvax Researchers at Los Angeles-based Immuvax reported continued return of cell-mediated immunity and clinical stability in AIDS patients one year after receiving inoculation with a putative non-pathogenic HIV-1 strain. The now...

AIDS patients relying more on hospital clinics than private doctors. (New Jersey)
July 22, 1991... New Jersey AIDS patients come to rely increasingly on hospital clinics rather than private doctors as their illness progresses, according to data newly released from a study of a statewide random sample of persons with AIDS in New...

Data show children tolerate AZT well. (Burroughs Wellcome)
July 22, 1991... Burroughs Wellcome Tolerance of Retrovir brand zidovudine (AZT) in children appears to be equivalent to that seen in adults, according to data presented by Terri Creagh-Kirk at the VII International Conference on AIDS in Florence,...

Researchers track change in AIDS risk behaviors. (Washington University, St. Louis)
July 22, 1991... Washington University, St. Louis Attempts to stem the spread of AIDS in America by providing only education about the disease to high-risk inner-city youth have backfired, according to a study directed by Arlene R. Stiffman, Ph.D.,...

Clinical trials announced. (NIAID, National Institute of Allergy and Infectious Diseases; clinical management of HIV and tuberculosis bacterium)
July 22, 1991... NIAID U.S. Department of Health and Human Services (HHS) Secretary Louis W. Sullivan, M.D., announced that the National Institute of Allergy and Infectious Diseases (NIAID) will launch three clinical trials involving approximately...

Prevention, treatment. and HIV/AIDS highlight conference. (National Hispanic Conference on Substance Abuse)
July 22, 1991... National Hispanic Conference on Substance Abuse The U.S. National Institute on Drug Abuse (NIDA), the Office for Substance Abuse Prevention, and the Office for Treatment Improvement will co-sponsor the National Hispanic Conference on...

Agreement reached with FDA. (Home Office Reference Laboratory's collection kit, OraSure)
July 22, 1991... Home Office Reference Laboratory Home Office Reference Laboratory Inc. (HORL), Lenexa, Kansas, announced that they have reached an agreement with the U.S. Food and Drug Administration (FDA) regarding the use of Epitope Inc.'s...

Structural biology as applied to the problem of targeted drug design, with potential applicability to the treatment of AIDS.
July 22, 1991... AUTHORS: RFA Available: GM-91-02. National Institute of General Medical Sciences. Application Receipt Date: March 18, 1992. Purpose: The U.S. National Institutes of Health (NIH) announces its interest in receiving applications to...

AIDS, euthanasia and grief.
July 22, 1991... AUTHORS: FMLG Van den Boom, C. Mead, T. Gremmen and H. Roozenburg. Netherlands Institute of Mental Health, Utrecht, The Netherlands, University of Leiden, Department of Psychology, The Netherlands. According to an abstract submitted...

Risk of endemic HIV and hepatitis B virus (HBV) transmission to patients during invasive procedures.
July 22, 1991... AUTHORS: D.M. Bell, W.J. Martone, D.H. Culver, H.S. Margolis, C.N. Shapiro, J.I. Tokars, R. Marcus, L.J. Furman, H.W. Jaffe, J.W. Curran and J.M. Hughes. Centers for Disease Control, Atlanta, Georgia. According to an abstract...

Changes in AIDs survival from 1984 to 1990 in the San Francisco GEneral Hospital cohort study.
July 22, 1991... AUTHORS: Dennis Osmond, S. Shiboski and A.R. Moss. University of California, San Francisco, and San Francisco General Hospital, San Francisco, California. According to an abstract submitted by the authors to the VII International...

Effect of therapy on risk of HIV-1 progression to AIDS and PCP.
July 22, 1991... AUTHORS: M.H. Graham Neil, S.L. Zeger, L.P. Park, J.P. Phair, R. Detels, S.H. Vermund, M. Ho and A.J. Saah. Multicenter AIDS Cohort Study, Bethesda, Maryland. According to an abstract submitted by the authors to the VII International...

566C80 is effective as salvage treatment for toxoplasma encephalitis.
July 22, 1991... AUTHORS: Henry Masur, D. O'Neill, I. Feuerstein, B. Baird, R. Walker, R.T. Davey, M.A. Polis, J. Falloon, G. Galetto, E. Seidel, S. Milwee, H.C. Lane and J.A. Kovacs. CCMD and U.S. National Institute for Allergy and Infectious Diseases...

Detection of HIV-1 DNA and infectious virus in cerebrospinal fluid.
July 22, 1991... AUTHORS: Anders Sonnerborg, B. Johansson and O. Strannegard. Department of Virology, the Central Microbiological Laboratory of Stockholm County Council, Department of Infectious Diseases, Roslagstull Hospital, Karolinska Institute,...

The cytopathic effect of HIV is correlated with the accumulation of histones.
July 22, 1991... AUTHORS: Anne Laurent-Crawford, Bernard Krust, Sylviane Muller, Luc Montagnier and Ara Hovanessian. Institut Pasteur, URA CNRS 1157, 25, rue du Dr. Roux, 75724 Paris, Cedex 15; CNRS, IBMC, 15, rue Rene Descartes, 67084 Strasbourg. ...

The use of an HIV-1 based retroviral vector to transfer antiviral constructs to human lymphocytes in vitro.
July 22, 1991... AUTHORS: Mark C. Poznansky, E. Langhoff, S. Lo, W.A. Haseltine and J. Sodroski. Dana-Farber Cancer Institute, Boston, Massachusetts. According to an abstract submitted by the authors to the VII International Conference on AIDS,...

Forecasting the medical care costs of the HIV epidemic in the United States: 1991-1994.
July 22, 1991... AUTHORS: Fred Hellinger, Ph.D. Agency for Health Care Policy and Research, U.S. Department of Health and Human Services. According to an abstract submitted by the author to the VII International Conference on AIDS, Florence, Italy,...

Recommendations for preventing transmission of HIV and HBV to patients during exposure-prone invasive procedures. (healthcare workers) (Morbidity and Mortality Weekly Report, July 12, 1991)
July 22, 1991... "This document has been developed by the Centers for Disease Control (CDC) to update recommendations for prevention of transmission of human immunodeficiency virus (HIV) and hepatitis B virus (HBV) in the healthcare setting. Current data...

Evidence from Zaire that breast-feeding by HIV-1-seropositive mothers is not a major route for perinatal HIV-1 transmission but does decrease morbidity.
July 22, 1991... SOURCE: AIDS, June 1991;5(6):709-714. A prospective study of children born to HIV+ mothers in Zaire shows that the benefits of breast feeding outweigh the risks of HIV transmission via breast milk. The study showed that the rate...

N-acetylcysteine inhibits latent HIV expression in chronically infected cells.
July 22, 1991... SOURCE: AIDS, June 1991;7(6):563-567. N-acetylcysteine (NAC) inhibits in vitro cytokine -stimulated HIV production in chronically infected monocytes and T-cell lines even more effectively than in acutely infected T cells and peripheral...

6-0-butanoylcastanospermine (MDL 28,574) inhibits glycoprotein processing and the growth of HIVS. (AIDS, June 1991, 693-698)
July 22, 1991... SOURCE: AIDS, June 1991;693-698. An acyl derivative of castanospermine is has 50 times the potency of a similar compound currently in clinical trials as a potential AIDS therapy, British researcher Debra L. Taylor and colleagues from...

Montagnier insists mycoplasma necessary cofactor for AIDS. (Luc Montagnier) (VII International Conference on AIDS)
July 15, 1991... VII International Conference on AIDS No stranger to controversy, HIV co-discoverer Luc Montagnier again put forward his theory that HIV requires a cofactor - possibly a mycoplasma - in order to cause disease. Montagnier's keynote...

U.S. AIDS cases to plateau in the next five years. (Johns Hopkins)
July 15, 1991... Johns Hopkins The annual number of newly diagnosed AIDS cases in the United States will plateau in the next five years, reports a Johns Hopkins School of Public Health researcher in the July 5, 1991, issue of Science. Ronald...

HIV patients with pneumonia surviving longer. (American Medical Association)
July 15, 1991... AMA AIDS patients suffering from acute respiratory failure (ARF) due to Pneumocystis carnii pneumonia (PCP) have better long-term prognosis than previously expected, according to a study published in the July 3, 1991, issue of Journal...

Global survey on HIV-related travel restrictions published. (Germany)
July 15, 1991... Germany The Deutsche AlDS-Hilfe, Berlin, Germany, the umbrella organization of Germany's 123 AIDS self-help organizations, has protested against restrictions on the mobility of people with HIV/AIDS. According to the organization,...

Study shows transfusion AIDS risk low. (University of California, San Francisco)
July 15, 1991... University of California, San Francisco A two-year study of more than 70,000 San Francisco blood donors has found that the risk of receiving blood infected with HIV is one in every 61,171 transfusions. The University of California...

Broadly protective AIDS vaccine deemed feasible. (RepliGen Corp.)
July 15, 1991... RepliGen Corp. Data presented at a VII International Conference on AIDS plenary session by Walter C. Herlihy, Ph.D., of Repligen Corporation, provides evidence that antibodies to one AIDS virus strain are capable of neutralizing a...

Company awarded up to 7.86 million pounds sterling under EUREKA initiative for AIDS vaccine. (British Bio-technology)
July 15, 1991... British Bio-technology British Bio-technology, an emerging pharmaceutical company, confirmed June 19, 1991, that it had received approval for a U.K. government grant, totalling up to Pounds 7.86 million, to be spread over 5 years. The...

Vaccine development examined. (Duke University Medical Center, Durham)
July 15, 1991... Duke University Medical Center, Durham In a presentation to the VII International Conference on AIDS, Dani P. Bolognesi of Duke University Medical Center, Durham, North Carolina, discussed the development of an AIDS vaccine. ...

AIDS prevention and healthcare of Paris prostitutes examined. (France)
July 15, 1991... France Lydia Braggiotti of the French National Association for Social Rehabilitation has studied the AIDS-relevant preventive measures adopted by 191 Paris prostitutes and the quality of the healthcare available to them. The study of...

Social and economic impact of AIDS. (Latin America and the Caribbean)
July 15, 1991... Latin America and the Caribbean Latin American and Caribbean countries are being rapidly affected by the AIDS epidemic - estimates indicate that between 500,000 and one million persons there are infected with HIV. Jaime...

Seroprevalence and seroconversion rates in New York City and Bangkok compared. (VII International Conference on AIDS)
July 15, 1991... VII International Conference on AIDS Despite the many cultural differences between New York City and Bangkok, Thailand, recent studies of intravenous drug users in the two cities suggest that large-scale behavior change appears to have...

Development specialist discusses demographic AIDS trap for women in Africa. (Josef Decosas)
July 15, 1991... Africa Sexual behavior is a key factor in the epidemiology of AIDS, and changing behavior is seen as a key factor in the fight against AIDS. In a presentation to the VII International Conference on AIDS, Josef Decosas, AIDS specialist...

High risk sexual practices continue among Nairobi men. (Kenya)
July 15, 1991... Kenya A majority of Kenyan men apparently feel invulnerable to AIDS and attempts to limit their high-risk sexual activities have had seemingly little impact so far, according to a recent study of behavioral attitudes in Nairobi, Kenya....

Speaker highlights AIDS impact on the family. (Dr. E. Maxine Ankrah) (Uganda)
July 15, 1991... Uganda Speaking to the VII International Conference on AIDS, Dr. E. Maxine Ankrah said that to adequately withstand the impact of AIDS, the disease must be viewed from a family perspective. "Family life has been the most affected by...

Seropositive mothers pose high risk for infant. (Kenya)
July 15, 1991... Kenya Between 39 and 45 percent of Kenyan children born of HIV seropositive mothers are themselves infected with the virus, according to Prahiba Datta of the University of Nairobi. Speaking at the VII International Conference on...

Home care for AIDS patients: a positive experiment. (Zambia)
July 15, 1991... Zambia Dr. Zebron Siankanga of the Salvation Army Hospital in the Southern Province of Zambia discussed the encouraging results of a home care program for AIDS patients at the VII International Conference on AIDS. The program...

Molecular basis for predicting patients' survival time examined. (University of California, San Francisco)
July 15, 1991... University of California, San Francisco Survival rates and clinical behavior of AIDS patients with non-Hodgkin's lymphoma, one of the serious and usually fatal diseases affecting AIDS patients, may be determined by the molecular...

Record number of minorities and women enroll in community-based AIDS studies. (VII International Conference on AIDS)
July 15, 1991... VII International Conference on AIDS The Community Programs for Clinical Research on AIDS (CPCRA), sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), have enrolled more than 3,000 participants in clinical...

New blood substitutes patent for recombinant hemoglobin. (Somatogen)
July 15, 1991... Somatogen Somatogen announced July 2, 1991, the issuance of United States Patent No. 5,028,588, entitled Blood Substitutes. This patent covers blood substitute products based on hemoglobin, which has been genetically engineered to...

Hemacare receives FDA licenses. (Food & Drug Administration Establishment License & various blood product licenses) (Sherman Oaks, California)
July 15, 1991... Sherman Oaks, California HemaCare Corporation, Sherman Oaks, California, announced the receipt of its U.S. Food and Drug Administration (FDA) Establishment License and various blood product licenses. These licenses allow HemaCare...

Health services research priority areas for accelerated small grant application review. (Research Report)
July 15, 1991... AUTHORS: PA: PA-91-62. Agency for Health Care Policy and Research. The Agency for Health Care Policy and Research (AHCPR) announces priority areas for small grant applications for health services research, including conferences,...

Passive immunization in ARC and AIDS patients: persistent neutralization of HIV-1 as monitored by polymerase chain reaction (PCR). (Research Report)
July 15, 1991... AUTHORS: Abraham Karpas, Fergal Hill, Brian Gazzard and Indira Hewlett. Department of Hematology, University of Cambridge, U.K., Westminster Hospital, London, U.K., DBBP, Food and Drug Administration, Bethesda, Maryland. From an...

Reversible inhibition of acute and chronic HIV-1 infection by an inhibitor of virus protease. (Research Report)
July 15, 1991... AUTHORS: Helmut Jacobsen, L. Ahlborn*Laake, R. Gugel and J. Mous. Hoffmann*La Roche Ltd., Basel, Switzerland. According to an abstract submitted by the authors to the VII International Conference on AIDS, Florence, Italy, June 16-21,...

Early versus later zidovudine treatment of symptomatic HIV infection: results of a VA cooperative study. (Veterans Affairs) (Research Report)
July 15, 1991... AUTHORS: J.D. Hamilton, P.M. Hartigan, M.S. Simberkoff, and the VA Cooperative Study Group. Department of Veterans Affairs, Washington, D.C. According to the abstract submitted by the authors to the annual meeting of the Association...

Does brief counseling reduce HIV risk in IV drug users?: final results from a randomized clinical trial. (Research Report)
July 15, 1991... AUTHORS: David R. Gibson, J. Lovelle-Drache and J.L. Sorenson. Center for AIDS Prevention Studies, University of California at San Francisco; Haight Ashbury Free Clinics, San Francisco, California. According to an abstract submitted by...

Allogenic bone marrow transplantation (BMT) combined with zidovudine (AZT) alpha-2 interferon (alpha-2-IFN) and donor HIV-1 specific T-cell clones in an AIDS patient. (Research Report)
July 15, 1991... AUTHORS: Giorgio La Nasa, C. Carcassi, A. Pizzati, M. Arras, A. Vacca, A. Ledde, A. Pintus, S. Atzeni, V. Sau, R. Boero, M. Mulargia, S. Orru, A.L. Leone and L. Contu. Chair of Medical Genetics, University of Cagliari, Italy. From an...

HIV seroprevalence and syphilis infection in psychiatric inpatients. (Research Report)
July 15, 1991... AUTHORS: M. Sacks, Helen Dermatis and S. Looser-Ott. Cornell University Medical College. From an abstract submitted by the authors to the VII International Conference on AIDS, Florence, Italy, June 17, 1991: "Objective: To determine...